Cointime update: China’s 2026 national medical insurance drug catalog and commercial health insurance innovative drug catalog were released in Suzhou, adding 107 medicines to the national reimbursement list. Among the additions are 51 Class 1 new drugs, a record high, covering oncology, rare diseases, chronic conditions and mental illness. The National Healthcare Security Administration announced the update.
China adds 107 drugs to national medical insurance list, including record 51 Class 1 new drugs
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
7m ago
Democrats to Probe Trump’s $100B Venezuela Oil Deal
1h ago
UBS Global Wealth Management Forecasts S&P 500 at 8,200 by End-2027
1h ago
Tencent Q3 2026 Revenue Rises 8% to RMB 207.3 Billion
2h ago
Onshore yuan closes at 6.6653 per dollar, up 2 pips
2h ago
Hong Kong’s Hang Seng closes down 0.91%; Zhipu jumps over 9%
3h ago
Goldman Sachs Forecasts Gold May Return to $5,600 by Late 2028